Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Tris Pharma, Inc. v. Actavis Laboratories FL, Inc.
Case Number:
21-1495
Court:
Nature of Suit:
830 Patent Infringement (Fed. Qst.)
Companies
Sectors & Industries:
-
July 07, 2022
Actavis Loss In ADHD Drug IP Fight Backed By Fed. Circ.
The Federal Circuit has upheld a ruling from Delaware's top federal judge that found a Teva unit failed to show three patents on the ADHD treatment Quillivant XR were invalid, finding the unit had not proved the judge made any errors.
-
March 03, 2022
IP Forecast: Tech Giants' Voice Tech Row Heads To Fed. Circ.
Microsoft and Google are heading to the Federal Circuit next week to challenge rulings by the Patent Trial and Appeal Board that partially upheld voice technology patents that are connected to Apple’s Siri brand and now owned by a Wi-LAN subsidiary. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
April 08, 2021
Teva Unit Urges Fed Circ. To Revive ADHD Drug Row
A Teva unit has urged the Federal Circuit to review a lower court's remand decision that held that its proposed generic version of ADHD treatment Quillivant XR infringed five valid Tris Pharma patents, saying the court was "not free to revisit undisturbed findings."